Skip to main content
Clinical Trials/CTRI/2023/11/059618
CTRI/2023/11/059618
Not yet recruiting
Phase 2

A comparative study to evaluate efficacy of intrathecal fentanyl and intrathecal midazolam added as adjuvant to Bupivacaine 0.5 (heavy) in patients undergoing LSCs - NI

Acharya Vinobha Bhave Rural Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Acharya Vinobha Bhave Rural Hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Acharya Vinobha Bhave Rural Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Age between 18 to 35years
  • 2\. Patients undergoing cesarean section
  • 3\. Primi gravida with gestational age more than 37 weeks
  • 4\. Body mass index 20 to 29\.9kg/meter square
  • 5\. Intact amniotic membrane
  • 6\. No history of bleeding tendency or coagulopathies or with any neuromuscular disorders or neurological diseases.
  • 7\. No previous uterine operations except cesarean sections
  • 8\. Living fetus
  • 10\. Patients giving informed consent.

Exclusion Criteria

  • 1\. Patients who are multigravida, previous LSCS.
  • 2\. ASA CLASS 3 AND CLASS 4\.
  • 3\. Patients refusal.
  • 4\. Patients with any co\-morbities.
  • 5\. Patients with infection at the site of injection.
  • 6\. Patients with sensitivity to local anaesthetic agent, fentanyl and midazolam.

Outcomes

Primary Outcomes

Not specified

Similar Trials